Drug Shortage Report for SEVOFLURANE
| Report ID | 151068 |
| Drug Identification Number | 02265974 |
| Brand name | SEVOFLURANE |
| Common or Proper name | SEVOFLURANE |
| Company Name | BAXTER CORPORATION |
| Market Status | MARKETED |
| Active Ingredient(s) | SEVOFLURANE |
| Strength(s) | 99.97% |
| Dosage form(s) | LIQUID |
| Route of administration | INHALATION INHALATION |
| Packaging size | 250mL bottle (CA2L9117) |
| ATC code | N01AB |
| ATC description | ANESTHETICS, GENERAL |
| Reason for shortage | Shortage of an inactive ingredient or component. |
| Anticipated start date | 2021-12-13 |
| Actual start date | 2021-12-13 |
| Estimated end date | 2022-01-19 |
| Actual end date | 2022-01-19 |
| Shortage status | Resolved |
| Updated date | 2022-01-20 |
| Company comments | For customers who have Sevoflurane vaporizers with a Draeger-fil or Safe-t-Seal filling port (refer to your device or current filling adaptor for reference), Sevoflurane with an integrated valve (code: CA2L9117SV DIN: 02265974) can be used as an alternative product. Request allocation release from Baxter Customer Care. Suprane (desflurane) (Code: CA2L9102ALU DIN:02227428) is also available as an alternative if it aligns with clinical practice. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 7125 MISSISSAUGA ROAD MISSISSAUGA, ONTARIO CANADA L5N 0C2 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2021-12-13 | English | Compare |
| v2 | 2021-12-13 | French | Compare |
| v3 | 2021-12-14 | English | Compare |
| v4 | 2022-01-06 | English | Compare |
| v5 | 2022-01-06 | French | Compare |
| v6 | 2022-01-07 | English | Compare |
| v7 | 2022-01-07 | French | Compare |
| v8 | 2022-01-19 | English | Compare |
| v9 | 2022-01-19 | French | Compare |
| v10 | 2022-01-20 | English | Compare |
Showing 1 to 10 of 10